FDA Approves Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or OSA
The US Food and Drug Administration (FDA) approved solriamfetol, which will be known be marketed by Jazz Pharmaceuticals as the brand name “Sunosi,” to improve wakefulness in adult patients with excessive daytime...
Read More